GeneDx Holdings (WGS) Capital Expenditures (2020 - 2026)
GeneDx Holdings (WGS) reported Capital Expenditures of $5.9 million for Q1 2026, up 169.23% year-over-year from $2.2 million in Q1 2025, and up 170.55% quarter-over-quarter from -$8.4 million in Q4 2025.
GeneDx Holdings (WGS) Capital Expenditures (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has 7 years of Capital Expenditures data on file, last reported at $5.9 million in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $5.9 million, up 169.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.0 million (up 129.92% YoY), and the FY2025 annual result was $6.3 million, up 142.05% from the prior year.
- Capital Expenditures grew to $5.9 million in Q1 2026 per WGS's latest filing, from -$8.4 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $8.9 million in Q3 2025 and troughed at -$8.4 million in Q4 2025.
- A 5-year average of $878352.9 and a median of $759000.0 in 2023 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 6029.31% in 2025 and fell as far as 5474.36% in 2025.
- A 5-year view of Capital Expenditures shows it stood at -$6.5 million in 2022, then jumped by 83.28% to -$1.1 million in 2023, then jumped by 114.36% to $156000.0 in 2024, then sank by 5474.36% to -$8.4 million in 2025, then surged by 170.55% to $5.9 million in 2026.
- Business Quant data shows WGS's Capital Expenditures at $5.9 million in Q1 2026, -$8.4 million in Q4 2025, and $8.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 39.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 376.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 237.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 8.27 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 76.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 22.14 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 127.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 38.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 17.41 Mn |
| 10 | GeneDx Holdings | 1.65 Bn | 1.48 Bn | 68.21 Mn | 5.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.92 Mn |
| Mar 31, 2026 | 5.92 Mn |
| Dec 31, 2025 | -8.38 Mn |
| Dec 31, 2025 | -8.38 Mn |
| Sep 30, 2025 | 8.92 Mn |
| Sep 30, 2025 | 8.92 Mn |
| Jun 30, 2025 | 3.56 Mn |
| Jun 30, 2025 | 3.56 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Dec 31, 2024 | 156,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Sep 30, 2024 | 1.94 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Mar 31, 2024 | 443,000.00 |
| Mar 31, 2024 | 443,000.00 |
| Dec 31, 2023 | -1.09 Mn |
| Dec 31, 2023 | -1.09 Mn |